Ding Ma1, Yuan Cheng1, Youyi Zhang2, Yanli Guo1, Zijian Li2, Geng Li1. 1. Department of Gynecology and Obstetrics, Peking University Third Hospital, Beijing 100191, China; 2. Institute of Vascular Medicine, Peking University Third Hospital and Key Laboratory of Cardiovascular Molecular Biology and Regulatory Peptide, Ministry of Health, Beijing 100191, China.
Abstract
OBJECTIVE: The high expression of cell division cycle 42 protein (CDC42) may be involved in the occurrence and progression of several tumors. However, the expression and function of CDC42 in cervical squamous cell carcinoma remains unclear. This study aimed to investigate the expression of CDC42 in cervical squamous cell carcinoma and its correlation with clinicopathologic characteristics. METHODS: The expression of CDC42 in 162 cervical squamous cell carcinoma tissue samples and 33 normal cervical tissue samples was investigated by immunohistochemistry. The CDC42 mRNA expression was detected by reverse transcription-polymerase chain reaction (RT-PCR). RESULTS: The cervical squamous cell carcinoma group showed a significantly higher CDC42 positive rate, compared to the normal cervical tissues (P<0.05). Furthermore, the tissues of stage II-IV carcinoma patients showed higher CDC42 expression levels compared to stage I patients (P=0.05). In addition, the expression of CDC42 was not correlated to age of patients, differentiation degree of cancer cells, or lymph node metastasis (P>0.05). Furthermore, compare with normal cervical tissues, the CDC42 mRNA expression in cervical cancer had no significant difference. CONCLUSIONS: CDC42 was up-regulated at protein level, but not mRNA level, in cervical squamous cell carcinoma. The high expression of CDC42 was correlated to the clinical stage of the patients, indicating that CDC42 might contribute to the progression of cervical squamous cell carcinoma.
OBJECTIVE: The high expression of cell division cycle 42 protein (CDC42) may be involved in the occurrence and progression of several tumors. However, the expression and function of CDC42 in cervical squamous cell carcinoma remains unclear. This study aimed to investigate the expression of CDC42 in cervical squamous cell carcinoma and its correlation with clinicopathologic characteristics. METHODS: The expression of CDC42 in 162 cervical squamous cell carcinoma tissue samples and 33 normal cervical tissue samples was investigated by immunohistochemistry. The CDC42 mRNA expression was detected by reverse transcription-polymerase chain reaction (RT-PCR). RESULTS: The cervical squamous cell carcinoma group showed a significantly higher CDC42 positive rate, compared to the normal cervical tissues (P<0.05). Furthermore, the tissues of stage II-IV carcinomapatients showed higher CDC42 expression levels compared to stage I patients (P=0.05). In addition, the expression of CDC42 was not correlated to age of patients, differentiation degree of cancer cells, or lymph node metastasis (P>0.05). Furthermore, compare with normal cervical tissues, the CDC42 mRNA expression in cervical cancer had no significant difference. CONCLUSIONS:CDC42 was up-regulated at protein level, but not mRNA level, in cervical squamous cell carcinoma. The high expression of CDC42 was correlated to the clinical stage of the patients, indicating that CDC42 might contribute to the progression of cervical squamous cell carcinoma.
Authors: Praveen Bhoopathi; Christopher S Gondi; Meena Gujrati; Dzung H Dinh; Sajani S Lakka Journal: Cell Signal Date: 2011-07-23 Impact factor: 4.315
Authors: Zhang Cuiyan; Hang Jie; Zhou Fang; Zhang Kezhi; Wan Junting; Shi Susheng; Feng Xiaoli; Li Ning; Mu Xinhua; Chen Zhaoli; Shao Kang; Qiu Bin; Li Baozhong; Chang Sheng; Xiong Meihua; He Jie Journal: Cancer Biol Ther Date: 2007-03-04 Impact factor: 4.742
Authors: Stephen Y Lai; Amy F Ziober; Megan N Lee; Noam A Cohen; Erica M Falls; Barry L Ziober Journal: Oral Oncol Date: 2007-11-09 Impact factor: 5.337
Authors: Teresa Gómez Del Pulgar; Fátima Valdés-Mora; Eva Bandrés; Rosa Pérez-Palacios; Carolina Espina; Paloma Cejas; Miguel Angel García-Cabezas; Manuel Nistal; Enrique Casado; Manuel González-Barón; Jesús García-Foncillas; Juan Carlos Lacal Journal: Int J Oncol Date: 2008-07 Impact factor: 5.650
Authors: Eleni Chrysanthou; Kylie L Gorringe; Chitra Joseph; Madeleine Craze; Christopher C Nolan; Maria Diez-Rodriguez; Andrew R Green; Emad A Rakha; Ian O Ellis; Abhik Mukherjee Journal: Breast Cancer Res Treat Date: 2017-04-27 Impact factor: 4.872